Correction
After publication of this work [1], we noted that we repeatedly had a typo mistake across the manuscript. The compound we used to test our cell lines was SCH772984 and not SCH722984. The typo was found misspelled in 54 occasions, including the title.
We also wanted to add an affiliation detail to the author’s list, as noted above.
We regret the mistake and upload this note to clarify it.
Reference
Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M. Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer. 2014;13:194. doi:10.1186/1476-4598-13-194.
Author information
Authors and Affiliations
Corresponding author
Additional information
Deborah JL Wong and Lidia Robert contributed equally to this work.
The online version of the original article can be found under doi:10.1186/1476-4598-13-194.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Wong, D.J., Robert, L., Atefi, M.S. et al. Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer 14, 128 (2015). https://doi.org/10.1186/s12943-015-0393-2
Published:
DOI: https://doi.org/10.1186/s12943-015-0393-2